MapLight Therapeutics, Inc. logo MPLT - MapLight Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 5
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $29.20 DETAILS
HIGH: $46.00
LOW: $13.00
MEDIAN: $28.00
CONSENSUS: $29.20
UPSIDE: 124.62%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.1 0.2 0.1 0.1 0.1 0.2 0 0 0.2 0.1 0.1
Gross Profit (0.1) (0.2) (0.1) (0.1) (0.1) (0.2) 0 0 (0.2) (0.1) (0.1)
Operating Expenses
R&D Expenses 53.4 53.7 64.5 27.1 26.7 19.6 20.7 16.8 15.5 15.2 10.4
SG&A Expenses 10.0 10.7 18.8 4.4 3.8 3.8 2.1 4.1 4.3 3.9 1.6
Other Expenses 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 63.4 64.3 83.2 31.5 30.5 23.4 22.8 20.9 19.8 19.1 12.0
Operating Income
Operating Income (63.5) (64.5) (83.4) (31.5) (30.7) (23.5) (22.8) (20.9) (20.0) (19.3) (12.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0
Interest Income 2.3 2.5 2.5 1.5 0.7 0.8 0.9 1.1 1.6 0.9 0.2
Profitability
EBITDA (63.4) (60.5) (79.4) (29.3) (29.7) (22.2) (21.0) (18.8) (18.2) (18.8) (11.9)
EBIT (63.5) (60.7) (79.5) (29.4) (29.8) (22.3) (21.2) (19.0) (18.4) (18.9) (12.0)
Income Before Tax (60.2) (60.7) (79.5) (29.4) (29.8) (22.3) (21.2) (19.0) (18.4) (18.9) (12.0)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0
Net Income (60.2) (60.7) (79.5) (29.4) (29.8) (22.3) (21.2) (19.0) (18.4) (18.9) (12.0)
Per Share Data
EPS (Basic) -1.32 -1.34 -1.81 -0.71 -0.72 -0.54 -0.51 -0.46 -0.44 -0.46 -0.29
EPS (Diluted) -1.32 -1.34 -1.81 -0.71 -0.72 -0.54 -0.51 -0.46 -0.44 -0.46 -0.29
Shares Outstanding 45.4 45.3 44.0 41.4 41.4 41.4 41.4 41.4 41.4 41.4 41.4
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q1 2023 Q1
Current Assets
Cash & Cash Equivalents 71.6 55.7 46.7 64.1 33.5 50.2 38.3 179.8 27.7
Short-Term Investments 233.1 254.4 258.4 163.0 27.0 42.1 70.5 0 0
Net Receivables 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 14.1 17.1 19.6 18.1 0 0 5.8 0 (27.7)
Total Current Assets 318.8 327.2 324.7 245.3 73.2 98.3 114.6 183.9 0
Non-Current Assets
Property, Plant & Equipment 2.5 6.2 6.6 6.6 6.9 7.2 7.6 6.4 0
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long-Term Investments 46.8 85.3 148.2 0 0.2 2.7 11.4 0.7 0
Other Non-Current Assets 0.2 0.0 0.1 5.3 3.8 3.4 3.4 1.7 0
Total Non-Current Assets 49.6 91.6 154.8 11.9 10.9 13.3 22.3 8.7 0
Total Assets 368.3 418.8 479.5 257.2 84.1 111.6 136.9 192.6 0
Current Liabilities
Account Payables 0 0 0 2.4 2.1 0.9 1.9 4.1 0
Short-Term Debt 1.2 0.9 0.9 0 0.8 0.8 0 0.5 0
Deferred Revenue 0 0 0 1.2 2.4 3.2 3.2 4.0 0
Other Current Liabilities 13.2 11.2 9.2 4.0 7.0 6.8 4.0 5.0 0
Total Current Liabilities 19.3 14.3 16.2 18.6 15.0 13.0 15.9 14.5 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 (20.9)
Total Non-Current Liabilities 0.8 4.7 4.9 5.1 5.4 5.6 5.8 5.3 (20.9)
Total Liabilities 20.0 19.0 21.1 23.7 20.4 18.6 21.7 19.7 (20.9)
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0 0 0 0 0 0
Retained Earnings (481.4) (421.2) (360.5) (281.0) (251.6) (221.7) (199.4) (140.7) 0
Accumulated Other Comprehensive Income (0.9) (0.9) (0.2) 0.0 0.1 0.1 0.2 0 (63.0)
Total Stockholders' Equity 348.3 399.8 458.4 233.5 63.8 93.0 115.2 172.8 20.9
Total Liabilities & Equity 368.3 418.8 479.5 257.2 84.1 111.6 136.9 192.6 0
Debt Metrics
Total Debt 2.0 5.6 5.8 6.0 6.2 6.4 6.6 5.8 0
Net Debt (69.6) (50.1) (40.9) (58.1) (27.3) (43.8) (31.7) (174.0) (27.7)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q1
Operating Activities
Net Income (60.2) (60.7) (79.5) (29.4) (29.8) (22.3) (21.2) (19.0) (18.4) (18.9) (12.0)
Depreciation & Amortization 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1
Stock-Based Compensation 0 0 0 0.1 0 0 0.2 0.4 0 0 0
Change in Working Capital 7.3 0.3 (1.7) (2.4) (5.2) (3.5) (0.5) (0.7) 0.2 (2.1) (0.5)
Other Non-Cash Items 7.8 9.1 34.3 (0.2) 0.9 0.2 (0.1) (0.7) 0.5 0.9 0.4
Operating Cash Flow (44.9) (51.2) (46.8) (31.8) (34.0) (25.6) (21.5) (19.9) (17.5) (19.9) (12.0)
Investing Activities
Capital Expenditure (0.0) (0.0) (0.4) (0.0) (0.1) 0 (0.1) (0.4) (0.3) (0.0) (0.1)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (19.8) 0 (266.2) (142.1) 0 0 0 (3.5) (121.5) 0 0
Sales/Maturities of Investments 80.5 67.0 24 6.5 17.5 37.5 32.5 12.5 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 60.7 67.0 (242.6) (135.6) 17.4 37.5 32.4 8.6 (121.8) (0.0) (0.1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (7.5) (3.9) (0.9) (0.2) (0.1) (0.0) (0.2) (2.0) 0 0
Financing Cash Flow 0.1 (6.9) 272.0 198.1 (0.2) (0.0) 0.0 (0.2) (1.7) 120.0 0.0
Cash Position
Net Change in Cash 15.9 9.0 (17.4) 30.7 (16.7) 50.2 10.9 (11.4) (179.8) 179.8 0
Cash at Beginning 55.7 46.7 64.1 33.7 50.2 0 27.5 39.0 179.8 0 0
Cash at End 71.6 55.7 46.7 64.4 33.5 50.2 38.5 27.5 0 179.8 0
Free Cash Flow (44.9) (51.2) (47.2) (31.8) (34.0) (25.6) (21.6) (20.2) (17.8) (19.9) (12.1)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.1) (0.2) (0.1) (0.1) (0.1) (0.2) 0 0 (0.2) (0.1) (0.1)
Operating Income (63.5) (64.5) (83.4) (31.5) (30.7) (23.5) (22.8) (20.9) (20.0) (19.3) (12.2)
Net Income (60.2) (60.7) (79.5) (29.4) (29.8) (22.3) (21.2) (19.0) (18.4) (18.9) (12.0)
EPS (Diluted) -1.32 -1.34 -1.81 -0.71 -0.72 -0.54 -0.51 -0.46 -0.44 -0.46 -0.29
Balance Sheet
Cash & Equivalents 71.6 55.7 46.7 64.1 33.5 50.2 38.3 179.8 27.7
Total Assets 368.3 418.8 479.5 257.2 84.1 111.6 136.9 192.6 0
Total Debt 2.0 5.6 5.8 6.0 6.2 6.4 6.6 5.8 0
Stockholders' Equity 348.3 399.8 458.4 233.5 63.8 93.0 115.2 172.8 20.9
Cash Flow
Operating Cash Flow (44.9) (51.2) (46.8) (31.8) (34.0) (25.6) (21.5) (19.9) (17.5) (19.9) (12.0)
Capital Expenditure (0.0) (0.0) (0.4) (0.0) (0.1) 0 (0.1) (0.4) (0.3) (0.0) (0.1)
Free Cash Flow (44.9) (51.2) (47.2) (31.8) (34.0) (25.6) (21.6) (20.2) (17.8) (19.9) (12.1)